Hanson & Doremus Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30
| Closed | -$32K | – | 444 |
|
|
2024
Q2 | $32K | Hold |
30
| – | – | 0.01% | 335 |
|
|
2024
Q1 | $29K | Hold |
30
| – | – | 0.01% | 342 |
|
|
2023
Q4 | $26K | Hold |
30
| – | – | ﹤0.01% | 346 |
|
|
2023
Q3 | $25K | Hold |
30
| – | – | 0.01% | 340 |
|
|
2023
Q2 | $22K | Hold |
30
| – | – | ﹤0.01% | 357 |
|
|
2023
Q1 | $25K | Hold |
30
| – | – | 0.01% | 352 |
|
|
2022
Q4 | $22K | Hold |
30
| – | – | ﹤0.01% | 391 |
|
|
2022
Q3 | $21K | Buy |
+30
| New | +$21K | 0.01% | 378 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$1K | – | 531 |
|
|
2021
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 491 |
|
|
2021
Q3 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 483 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 500 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 532 |
|